Action 600998 JOINTOWN PHARMACEUTICAL GROUP CO., LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Jointown Pharmaceutical Group Co., Ltd

Actions

600998

CNE100000W45

Cours en clôture Shanghai S.E.
Autres places de cotation
 00:00:00 25/04/2024 		Varia. 5j. Varia. 1 janv.
8,21 CNY -0,24 % Graphique intraday de Jointown Pharmaceutical Group Co., Ltd -2,96 % +17,12 %
08/04 Jointown Pharmaceutical met en place un laboratoire d'intelligence artificielle commun avec le campus de Wuhan de l'Université de Pékin MT
2023 Jointown Pharmaceutical Group Co., Ltd publie ses résultats pour les neuf mois clos le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus
Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Jointown Pharma's Unit Gets Nod for Registration of Acarbose Tablets
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
Jointown Pharmaceutical Group Co., Ltd announces decision of Regulatory Authority on the transaction
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
Jointown Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 26, 2022, has expired with 36,138,098 shares, representing 1.94% for CNY 425.67 million.
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
Jointown Pharmaceutical Group Co., Ltd announced that it expects to receive CNY 2.33 billion in funding
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Nanjing Puguang Biotechnology Co., Ltd announced that it has received $15 million in funding from Huatai Zijin Investment Co. Ltd, Nanjing XinGong Investment Group Co., Ltd, Shanghai Wenzhou Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
Amcare Lab announced that it has received $31 million in funding from Jointown Pharmaceutical Group Co., Ltd, Technology Financial Group, Fosun Group, K2VC, Bison Capital Asset Management, LLC, CICC Capital Management Co., Ltd.
Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 600 million worth of its shares.
Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 600998
  4. Actualités Jointown Pharmaceutical Group Co., Ltd
  5. Autres langues